Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 13:16:1641285.
doi: 10.3389/fimmu.2025.1641285. eCollection 2025.

Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients

Affiliations

Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients

Laura E Martínez-Gómez et al. Front Immunol. .

Abstract

Background: Cytokines and chemokines are essential for establishing an appropriate immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Variations in the genes encoding cytokines and chemokines strongly influence the immune response to pathogenic challenges and disease outcomes. This study was conducted to investigate the associations between polymorphisms in the TNF-α, IL-6, IL-8, IL-10, and CCL5 genes and COVID-19 severity.

Methodology: We performed a cross-sectional study with a total of 627 unvaccinated COVID-19 patients were classified according to WHO disease severity. We evaluated the levels of IFN-α, IFN-γ, TNF-α, IL-1Ra, IL-2, IL-6, IL-7, IL-10, CCL2, CCL3, CXCL8, CXCL10 and GCSF in the serum and compared them among COVID-19 severity groups by Kruskal-Wallis test and stratified by polymorphism alleles. A logistic regression was performed to determine the association of the polymorphism and COVID-19 severity.

Results: This study revealed a significant increase in IL-2, IL-6 and CCL-2 levels in the deceased group. However, the IL-10 levels were higher in the moderate group than in the mild group. Logistic regression analysis revealed that five polymorphisms were associated with a higher risk of severe COVID-19: the TNF-α (rs1800610) A allele (OR=1.50; 95% CI: 1.01-2.24); the IL-6 (rs1800796) C allele (OR=1.64; 95% CI: 1.05-2.57); the IL-10 (rs1800871) T allele (OR=1.94; 95% CI: 1.24-3.04) and (rs1800872) A allele (OR=1.87; 95% CI: 1.21-2.89); and the CCL5 (rs3817656) G allele (OR= 1.64; 95% CI: 1.02-2.65).

Conclusion: Patients infected with SARS-CoV-2 who have the TNFα gene variant (rs1800629) are protected from developing COVID-19 moderate and severe outcomes, as well as from presenting low concentrations of some pro-inflammatory cytokines and chemokines. However, carriers of the IL-10 (rs1800872, rs1800871) and CCL-5 (rs2107538) gene variants were associated with patients who died from COVID-19. Of these, only the minor allele of CCL-5 was primarily associated with increased chemokines levels, as well as with some cytokines considered hallmarks of the cytokine storm.

Keywords: CCL-2; COVID-19; IL-10; IL-6; SARS-CoV-2; polymorphism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Association of the Polymorphisms of TNFα (rs1800610, rs1800629, rs3093664), IL-6 (rs1800796, rs10499563), IL-10 (rs1800872 and rs1800071), and CCL5 (rs2107538, rs3817656) genes and COVID-19 outcomes. c, Codominant; d, dominant; r:recesive. OR (CI). Association statistically significant differences among groups. The models were adjusted by the main covariates: type two diabetes, obesity, hypertension, sex and age.
Figure 2
Figure 2
Association of the SNPs and cytokines, with COVID-19 severity.

References

    1. Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. (2021) 137:155323. doi: 10.1016/j.cyto.2020.155323, PMID: - DOI - PMC - PubMed
    1. Yessenbayeva A, Apsalikov B, Massabayeva M, Kazymov M, Shakhanova A, Mussazhanova Z, et al. Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population. PloS One. (2023) 18:e0288139. doi: 10.1371/journal.pone.0288139, PMID: - DOI - PMC - PubMed
    1. Zanza C, Romenskaya T, Manetti AC, Franceschi F, La Russa R, Bertozzi G, et al. Cytokine storm in COVID-19: immunopathogenesis and therapy. Med (Kaunas). (2022) 58. doi: 10.3390/medicina58020144, PMID: - DOI - PMC - PubMed
    1. Fricke-Galindo I, Falfán-Valencia R. Genetics insight for COVID-19 susceptibility and severity: A review. Front Immunol. (2021) 12:622176. doi: 10.3389/fimmu.2021.622176, PMID: - DOI - PMC - PubMed
    1. Chakravarty S. COVID-19: the effect of host genetic variations on host-virus interactions. J Proteome Res. (2021) 20:139–53. doi: 10.1021/acs.jproteome.0c00637, PMID: - DOI - PubMed

LinkOut - more resources